108 related articles for article (PubMed ID: 19234159)
1. Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTL.
Benlalam H; Jalil A; Hasmim M; Pang B; Tamouza R; Mitterrand M; Godet Y; Lamerant N; Robert C; Avril MF; Neefjes J; Tursz T; Mami-Chouaib F; Kieda C; Chouaib S
J Immunol; 2009 Mar; 182(5):2654-64. PubMed ID: 19234159
[TBL] [Abstract][Full Text] [Related]
2. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
[TBL] [Abstract][Full Text] [Related]
3. The decreased susceptibility of metastatic melanoma cells to killing involves an alteration of CTL reactivity.
Gassara A; Messai Y; Gaudin C; Abouzahr S; Jalil A; Diarra-Mehrpour M; Faure F; Richon C; Avril MF; Even J; Chouaib S
Int J Oncol; 2006 Jul; 29(1):155-61. PubMed ID: 16773195
[TBL] [Abstract][Full Text] [Related]
4. Gap junctions at the dendritic cell-T cell interface are key elements for antigen-dependent T cell activation.
Elgueta R; Tobar JA; Shoji KF; De Calisto J; Kalergis AM; Bono MR; Rosemblatt M; Sáez JC
J Immunol; 2009 Jul; 183(1):277-84. PubMed ID: 19542439
[TBL] [Abstract][Full Text] [Related]
5. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
Besser MJ; Schallmach E; Oved K; Treves AJ; Markel G; Reiter Y; Schachter J
Cytotherapy; 2009; 11(2):206-17. PubMed ID: 19148842
[TBL] [Abstract][Full Text] [Related]
6. Information sharing and collateral damage.
Li G; Herlyn M
Trends Mol Med; 2005 Aug; 11(8):350-2. PubMed ID: 16002338
[TBL] [Abstract][Full Text] [Related]
7. Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells.
Mendoza-Naranjo A; Saéz PJ; Johansson CC; Ramírez M; Mandakovic D; Pereda C; López MN; Kiessling R; Sáez JC; Salazar-Onfray F
J Immunol; 2007 Jun; 178(11):6949-57. PubMed ID: 17513744
[TBL] [Abstract][Full Text] [Related]
8. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N
Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056
[TBL] [Abstract][Full Text] [Related]
9. Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune?
Hamaï A; Benlalam H; Meslin F; Hasmim M; Carré T; Akalay I; Janji B; Berchem G; Noman MZ; Chouaib S
Tissue Antigens; 2010 Jan; 75(1):1-8. PubMed ID: 20196816
[TBL] [Abstract][Full Text] [Related]
10. MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
Godet Y; Moreau-Aubry A; Guilloux Y; Vignard V; Khammari A; Dreno B; Jotereau F; Labarriere N
J Exp Med; 2008 Oct; 205(11):2673-82. PubMed ID: 18936238
[TBL] [Abstract][Full Text] [Related]
11. Identification of genes differentially expressed in melanoma sublines derived from a single surgical specimen characterised by different sensitivity to cytotoxic T-lymphocyte activity.
Kocher T; Schraml P; Spagnoli GC; Harder F; Heberer M
Schweiz Med Wochenschr; 2000 Apr; 130(17):617-24. PubMed ID: 10829299
[TBL] [Abstract][Full Text] [Related]
12. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
13. CTL induction by cross-priming is restricted to immunodominant epitopes.
Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
[TBL] [Abstract][Full Text] [Related]
14. The requirements for CTL-mediated rejection of cancer in humans: NKG2D and its role in the immune responsiveness of melanoma.
Wang E; Selleri S; Marincola FM
Clin Cancer Res; 2007 Dec; 13(24):7228-31. PubMed ID: 18094399
[No Abstract] [Full Text] [Related]
15. Cross-presentation by intercellular peptide transfer through gap junctions.
Neijssen J; Herberts C; Drijfhout JW; Reits E; Janssen L; Neefjes J
Nature; 2005 Mar; 434(7029):83-8. PubMed ID: 15744304
[TBL] [Abstract][Full Text] [Related]
16. Direct antigen presentation and gap junction mediated cross-presentation during apoptosis.
Pang B; Neijssen J; Qiao X; Janssen L; Janssen H; Lippuner C; Neefjes J
J Immunol; 2009 Jul; 183(2):1083-90. PubMed ID: 19553546
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gap junctions in melanoma and their impact on Melan-A/MART-1-specific CD8⁺ T lymphocyte emergence.
Benlalam H; Carré T; Jalil A; Noman Z; Caillou B; Vielh P; Tittarelli A; Robert C; Chouaib S
J Mol Med (Berl); 2013 Oct; 91(10):1207-20. PubMed ID: 23744108
[TBL] [Abstract][Full Text] [Related]
18. Cx43-Gap Junctions Accumulate at the Cytotoxic Immunological Synapse Enabling Cytotoxic T Lymphocyte Melanoma Cell Killing.
Hofmann F; Navarrete M; Álvarez J; Guerrero I; Gleisner MA; Tittarelli A; Salazar-Onfray F
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547237
[TBL] [Abstract][Full Text] [Related]
19. Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4.
Zhang T; Somasundaram R; Berencsi K; Caputo L; Gimotty P; Rani P; Guerry D; Swoboda R; Herlyn D
Eur J Immunol; 2006 Feb; 36(2):457-67. PubMed ID: 16421945
[TBL] [Abstract][Full Text] [Related]
20. Flow Cytometry Evaluation of Gap Junction-Mediated Intercellular Communication Between Cytotoxic T Cells and Target Tumor Cells.
Navarrete M; Salazar-Onfray F; Tittarelli A
Methods Mol Biol; 2021; 2346():225-236. PubMed ID: 33029747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
